Tetra Bio Pharma Inc TBPMQ

RE:Reduvo submission to health canada

[SamV21]

Reduvo submission is reviewed under "submissions relying on 3rd party data"  so it shouldn't take long time.( Misleading ,You have no idea how long it will take or if it will be approved , pull up some submitted applications to see how long it took for some simple drugs) Keep in mind the drug is used in six countries already.Reduvo is not currently sold any where in the world , there might be variations of it , it is the DIN number that makes it original. currently health Canada reviewing 5 such similar submissions including tetra Reduvo He pulled the list and did not look at what drugs or creams or what was being applied for  , its not like standing in line at the bank . The submissions all these are made this year from March to august. It looks like all earlier submissions are cleared.(wrong again each drug is different ,REDUVO IS A NARCOTIC IT WILL TAKE LONGER than a skin product takes or a minor medication. So 6 to 8 months from may is November or December this year time frame. Link to health Canada page below. The table can be sorted by dates or type.
Yes go to this table and put in some stronger drugs and look at those time lines..
SO MISLEADING TOTAL PUMPING and minimalizing putting a NARCOTIC DRUG  through HEALTH CANADA , it does not matter what the rest of the world is doing Heath Canada banned Dronabinol in 1985 

https://www.canada.ca/en/health-canada/services/drug-health-product-review-approval/submissions-under-review/new-drug-submissions-under-review.html

Submission Relying on Third-Party Data (SRTD) – a new drug submission (or supplement) substantially relying on literature and market experience. In the absence of clinical study reports to support the safety and efficacy of a proposed product or medicinal ingredient, sponsors seek to satisfy the evidence requirements of the Food and Drug Regulations [namely, C.08.002(2)(g) and (h)] by way of a reference product (as reported in the literature) and its domestic and/or foreign market experience. It is understood that the safety and efficacy evidence of a SRTD may not necessarily be derived from studies using the same formulation or manufacturer of the drug for which a Notice of Compliance (NOC) is being sought.

They may want additional information nothing is a done deal when you go to Health Canada, everyone seems to understand this except this PUMPER .